BaralSD, PoteatT, StromdahlS, WirtzAL, GuadamuzTE, BeyrerC. Worldwide burden of HIV in transgender women: A systematic review and meta-analysis. Lancet Infect Dis, 2013; 13:214–222.
2.
Centers for Disease Control and Prevention.. CDC Fact Sheet: Trends in U.S. HIV Diagnoses, 2005–2014. Atlanta, GA: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; Centers for Disease Control and Preventio, 2015.
3.
SantosG-M, WilsonEC, JinH, et al.HIV care continuum for transgender women in respondent driven sampling study in San Francisco, July 20–25 2013, abstract MOPE163. 20th International AIDS Conference. Melbourne, Australia, 2014.
4.
WilsonEC, ChenYH, ArayasirikulS, et al.Differential HIV risk for racial/ethnic minority trans*female youths and socioeconomic disparities in housing, residential stability, and education. Am J Public Health, 2015:e1–e7.
5.
WilsonEC, JinH, LiuA, RaymondHF. Knowledge, indications and willingness to take pre-exposure prophylaxis among transwomen in San Francisco, 2013. PLoS One, 2015; 10:e0128971.
6.
WilsonEC, JinH, LiuA, RaymondHF. Knowledge, indications and willingness to take pre-exposure prophylaxis among transwomen in San Francisco, 2013. PLoS One, 2015; 10:e0128971.
7.
WilsonEC, SantosGM, RaymondHF. Sexual mixing and the risk environment of sexually active transgender women: Data from a respondent-driven sampling study of HIV risk among transwomen in San Francisco, 2010. BMC Infect Dis, 2014; 14:430.
8.
AuerbachJD, KinskyS, BrownG, CharlesV. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDS, 2015; 29:102–110.
9.
YoungB, ZunigaJM, MontanerJ, MayerKH. Controlling the HIV epidemic with antiretrovirals: Moving from consensus to implementation. Clin Infect Dis, 2014; 59:S1–S2.
10.
MimiagaMJ, CaseP, JohnsonCV, SafrenSA, MayerKH. Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: Limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr, 2009; 50:77–83.
11.
CohenSE, VittinghoffE, BaconO, et al.High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: Baseline data from the US PrEP demonstration project. J Acquir Immune Defic Syndr, 2015; 68:439–448.
12.
AghaizuA, MerceyD, CopasA, JohnsonAM, HartG, NardoneA. Who would use PrEP? Factors associated with intention to use among MSM in London: A community survey. Sex Transm Infect, 2013; 89:207–211.
